Sort
48,018 grants matching “immunotherapy”
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS
$472,452Ninh La-Beck · Texas Tech University Health Scis Center · R01 · FY2025 · CA
Preclinical and clinical characterization of DNMT inhibitors +/- standard chemoimmunotherapy in TNBC
$472,447Liewei Wang · Mayo Clinic Rochester · R01 · FY2025 · CA
The Antigen Repertoire of CD4 T cells from Pancreatic Islets
$472,396Maki Nakayama · University Of Colorado Denver · R01 · FY2023 · DK
Eastern Cooperative Oncology Group
$472,390Fox Chase Cancer Center · U10 · FY2005 · CA
Structure and Functional Consequences of Serine vs. Threonine Mucin-Type O-linked Glycosylation
$472,388Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Design of novel antitumor immunotherapies based on tumor-associated glycopeptide antigens
$472,388Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system
$472,383Harald Paganetti · Massachusetts General Hospital · R01 · FY2023 · CA
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$472,379Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Immunosurveillance and Immunopathology Core
$472,311Sabarinathan Ramachandran · University Of Minnesota · U19 · FY2025 · AI
Cancer Immunology Training Grant
$472,299Kai W Wucherpfennig · Dana-Farber Cancer Inst · T32 · FY2017 · CA
Core B: Biostatistics and Data Management
$472,259Ted Gooley · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Core B: Biostatistics and Data Management
$472,259Ted Gooley · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Core 3: Mouse Models Core (MM Core)
$472,258Geoffrey Myles Wahl · Salk Institute For Biological Studies · P01 · FY2024 · CA
Structural and functional characterization of T and NK cell receptors
$472,217Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$472,215Lily Yang · Emory University · R01 · FY2025 · CA
Breast and Other Carcinoma Clinical Trials Using Immunotherapies
$472,182Margaret Gatti-Mays · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cancer Immunotherapy Clinical Trials
$472,182Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cancer Immunology Training Grant
$472,152Kai W Wucherpfennig · Dana-Farber Cancer Inst · T32 · FY2018 · CA
Fast Targeted Spectroscopic Imaging for Brain Tumor Imaging at 3T and 7T
$472,134Jullie W Pan · University Of Missouri-Columbia · R01 · FY2021 · EB
Deciphering TREM1/2 Function in Primary Brain Cancer Using a New Model of Glioblastoma
$472,124Alain Charest · Beth Israel Deaconess Medical Center · R21 · FY2024 · NS
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$472,110Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2022 · EB
Project 2: Integrating race, ethnicity, and genomic ancestry across GENIE to understand genetic and environmental contributions to pan-cancer risk, prognosis, and outcomes
$472,108Jian Zhang · Sloan-Kettering Inst Can Research · P01 · FY2024 · CA
Image-guided radiation-induced permeability (IGRIP) for IGDD
$472,098Stephen J. Kron · University Of Chicago · R01 · FY2019 · CA
NK Memory
$472,064Lewis L. Lanier · University Of California, San Francisco · R01 · FY2017 · AI
Breaking down tumor immune privilege through targeted hypoxia reduction
$472,058Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA